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Abstract
Renal transplant recipients (RTR) are highly susceptible to urinary tract infections (UTIs) with over 50% of patients
having at least one UTI within the first year. Yet it is generally acknowledged that there is considerable insensitivity
and inaccuracy in routine urinalysis when screening for UTIs. Thus a large number of transplant patients with
genuine urine infections may go undiagnosed and develop chronic recalcitrant infections, which can be associated
with graft loss and morbidity. Given a recent study demonstrating ATP is released by urothelial cells in response to
bacteria exposure, possibly acting at metabotropic P2Y receptors mediating a proinflammatory response, we have
investigated alternative, and possibly more appropriate, urinalysis techniques in a cohort of RTRs.
Mid-stream urine (MSU) samples were collected from 53 outpatient RTRs. Conventional leukocyte esterase and
nitrite dipstick tests, and microscopic pyuria counts (in 1 μl), ATP concentration measurements, and identification of
intracellular bacteria in shed urothelial cells, were performed on fresh unspun samples and compared to
‘gold-standard’ bacterial culture results.
Of the 53 RTRs, 22% were deemed to have a UTI by ‘gold-standard’ conventional bacteria culture, whereas 87%, 8%
and 4% showed evidence of UTIs according to leukocyte esterase dipstick, nitrite dipstick, and a combination of
both dipsticks, respectively. Intracellular bacteria were visualized in shed urothelial cells of 44% of RTRs, however
only 1 of the 23 RTRs (44%) was deemed to have a UTI by conventional bacteria culture. A significant association of
the ‘gold-standard’ test with urinary ATP concentration combined with visualization of intracellular bacteria in shed
urothelial cells was determined using the Fisher’s exact test.
It is apparent that standard bedside tests for UTIs give variable results and that seemingly quiescent bacteria in
urothelial cells are very common in RTRs and may represent a focus of subclinical infection. Furthermore, our results
suggest urinary ATP concentration combined with detection of intracellular bacteria in shed urinary epithelial cells
may be a sensitive means by which to detect ‘occult’ infection in RTRs.
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Background
Renal transplant recipients (RTRs) are susceptible to urin-
ary tract infections (UTIs), which are the commonest post
transplant infections, and approximately 40% of patients
go on to get recurrent UTIs (Mitra and Alangaden 2011).
In a review of 30,000 patients, those with post-transplant
UTIs had a 3-fold greater risk of death and a 2-fold greater
risk of graft loss than those without (Abbott et al. 2004).
The standard routine clinical-practice tests currently
used to diagnose UTIs regularly misdiagnose infection
and antibiotics are often not prescribed when appropriate
(Franz and Horl 1999), which may explain the recurrence
in many cases (Manges et al. 2001). Approximately 65% of
recurring UTIs seem to be caused by the same micro-
organism, and evidence suggests this may be due to
chronic sub-clinical ‘intracellular’ bladder wall infection
(Anderson et al. 2003). This evidence is supported by data
demonstrating that conventional diagnostic tests only give
a positive result in 14% of all patients who were subse-
quently diagnosed with recurrent UTIs, highlighting the
need for improvement (van Haarst et al. 2001; Arinzon
et al. 2009).
Failure to diagnose a common UTI, such as cystitis,
may increase UTI severity by allowing progression from
the lower to the upper urinary tract. One study found
that up to 33% of RTRs with UTIs went on to develop
acute pyelonephritis (APN) (Valera et al. 2006). Without
treatment, APN can lead to bacteraemia, renal failure
and sepsis (Rubin 1993). Acute kidney infection is also
an independent risk factor for the deterioration of graft
function and may increase the risk of subsequent acute
rejection (Pelle et al. 2007). Given its severity and pos-
sible implications on graft function in RTRs, it is clear to
see why early detection to facilitate effective treatment
of UTIs is at the crux of the issue.
Unfortunately, UTI diagnosis is often problematical
due to the absence of symptoms. This is an issue espe-
cially relevant to RTRs, who are more likely to suffer
from clinically asymptomatic UTIs than their non-
immunocompromised counterparts (Saemann and Horl
2008). As yet, this is an unavoidable consequence of the
immunosuppressive drugs taken post-transplantation,
which prevent the mounting of a conventional inflam-
matory response to infection (Gangappa et al. 2008). In
addition to immunosuppressive drugs, RTRs routinely
receive combination antibiotic therapy (e.g. trimetho-
prim and sulfamethoxazole [Trim/Sul]) for the first 3–
12 months (in the UK) following transplantation to pre-
vent Pneumocystis jirovecia infection. However, it is be-
lieved that as a result of antibiotic resistance, and/or the
low doses routinely used, Trim/Sul is not completely ef-
fective against UTIs, and this may result in persistent
sub-clinical infections. Ultimately there is an inherent
difficulty in identifying UTIs in RTRs.
UTI is responsible for approximately 40-50% of all in-
fectious complications post transplantation and is also
found to be a more common affliction in RTRs than in
the general population (Chan et al. 1990; Rabkin et al.
1998; Glazier et al. 1998). For these reasons, an effective
diagnosis would present significant benefits. Previous
studies have suggested alternative urinalysis for UTI detec-
tion (e.g. quantification of microscopic pyuria, visualization
of intracellular bacteria in shed urothelial cells, urinary
interleukin [IL] levels, and urinary ATP concentration) and
although reported to be less powerful that the current ‘gold
standard’ in the general population, the possibility exists
that they may be appropriate for an immunocompromised
RTR cohort (Stamm 1983; Lundin et al. 1989; Miliotis
1991; Ivancic et al. 2008). In support of this notion, Säve
and Persson have recently demonstrated that ATP is re-
leased by urothelial cells in response to uropathogenic
Escherichia coli exposure, possibly acting at metabotropic
P2Y receptors mediating a proinflammatory IL-8 response
(Save and Persson 2010). That the IL-8 response is likely
dampened in immunosuppressed RTRs does not, to our
minds, infer that ATP release from infected urothelial cells
is also suppressed.
By investigating alternative diagnostic methods (i.e.
quantification of microscopic pyuria and urinary ATP
concentration, and visualization of intracellular bacteria
in shed urothelial cells; see Methods) in this cross-
sectional, one-time sampling, preliminary investigation
we hope to shed light on a key issue involving both patient
welfare and economic impact. We hypothesize, bacterial
colonization of shed urothelial cells and high levels of
urinary ATP (i.e. >50 nmol/l; presumably as a result of a
proinflammatory response involving the purinergic sys-
tem) is a powerful marker of UTI in RTRs when com-
pared to the current ‘gold standard’ culture test.
Methods
53 patients who underwent renal transplantation at the
Royal Free Hospital, London, UK, between the years 2009–
2012 were included in this study. Transplant recipients
were recruited within 2–4 weeks following transplantation
(i.e. >2 weeks before stent removal). All subjects were
monitored for UTIs upon recruitment and urinalysis was
performed on mid-stream urine (MSU) samples.
Urinalysis comprised of i) routine clinical-practice bed-
side leukocyte esterase and nitrite dipstick tests (read using
a bedside automated analyzer), ii) routine clinical-practice
bacterial culture on Columbia blood agar plates, iii) non-
routine quantification of microscopic pyuria in 1 μl of fresh
unspun urine using a haemocytometer as previously
described (Stamm 1983), iv) non-routine quantification of
urinary ATP concentration in 50 μl of fresh unspun urine,
using a luciferin/luciferase assay (ATP Bioluminiscence
Assay Kit, detection range 2x10−10 – 2x10−4 M ATP;
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Sigma, Poole, UK) and a luminometer (Synergy 2, Biotek,
Winooski, USA), as previously described (Lundin et al.
1989), and v) non-routine identification of bacteria present
both in the intracellular domain, and on the surface, of
shed transitional epithelial (urothelial) cells in an
unfixed cytospin cell preparation (800 rpm, 5 min, at
room temperature, prepared from 100 μl of fresh urine;
Sandon Cytospin 4, York, UK), using acridine orange
and crystal violet stains (Miliotis 1991) and fluores-
cence microscopy (Leica Nicrosystems GmgH, DMIRB,
Wetlar, Germany). Immunocytochemistry and fluores-
cence microscopy was retrospectively performed on
samples with confirmed intracellular bacteria using
anti-uroplakin III (UPIII, 1:200, overnight incubation;
Santa Cruz Biotechnology, Santa Cruz, USA) and a
FITC conjugated secondary antibody (1:1000 for 2 h;
1:1000; Invitrogen, Paisley, UK) to verify the cells as
urothelial cells (as opposed to other epithelial cells e.g.
of renal or vaginal origin).
A two-tailed Fisher’s exact test was used to test for as-
sociations between routine clinical-practice ‘gold-standard’
culture tests and each of the following tests: leukocyte es-
terase dipstick, nitrite dipstick, microscopic pyuria, urin-
ary ATP concentration, and visualization of intracellular
bacteria in shed urothelial cells. The performance of the
various diagnostic tests were evaluated by the following
metrics: sensitivity, specificity (i.e., positive predictive
value [PPV], positive likelihood ratio [LR+], negative likeli-
hood ratio [LR-], accuracy, Youden's index and the diag-
nostic odds ratio [DOR]). The formulae used for each
metric are summarized in Table 1. The metrics and associ-
ated confidence intervals were calculated using Microsoft
Excel and Instat (GraphPad Software Inc, La Jolla, USA).
An ethics board, specifically the Moorfields and
Whittington Hospitals Research Ethics Committee, ap-
proved this study.
Results and discussion
A total of 53 urine samples were collected from 53 renal
transplant recipients. The majority of patients (n = 41;
77%) tested negative for the presence of bacteria above
the threshold of 105 colony-forming units per ml
(CFU ml−1; deemed the ‘gold-standard’ for diagnosing a
UTI). Interestingly, 50% of those testing positive (n = 6)
were asymptomatic – further highlighting the high inci-
dence of clinically asymptomatic UTIs in immunocom-
promised RTRs.
Almost the entire patient group (n = 46; 87%) tested
positive for leukocyte esterase (i.e. gave a reading of +2 or
+3 according to the bedside automated analyzer). How-
ever of those testing positive, only 13% (n = 6) also tested
positive for the presence of bacteria above 105 CFU ml−1.
A significant association of the ‘gold-standard’ test and
leukocyte esterase test was determined using the Fisher’s
exact test (P < 0.01). In contrast to leukocyte esterase, a
minority of patients (n = 4; 8%) tested positive for nitrites.
Of those testing positive for nitrites, 50% (n = 2) also
tested positive for the presence of bacteria above
105 CFU ml−1. The majority (80%, n = 39) of those testing
negative for nitrites were also culture negative. When
combining leukocyte esterase and nitrite dipstick tests,
only 7 patients (14%) showed parity (i.e. both tests were
positive, or both tests were negative). Zero patients tested
positive for both dipsticks and positive for the presence of
bacteria above 105 CFU ml−1, and only 2% (n = 1) tested
negative for both dipsticks and bacteria levels below
105 CFU ml−1.
The majority of patients (n = 44; 83%) were found to
have microscopic pyuria levels of ≥10 white blood cells
(WBC) in 1 μl of fresh unspun urine; proposed as indica-
tive of a UTI (Stamm 1983). Of those found to have
microscopic pyuria, 82% (n = 36) had pyuria levels ranging
from 10–40 WBC in 1 μl of fresh unspun urine.
A concentration of ATP, ≥50 nM, in 50 μl of fresh unspun
urine (i.e. ≥50 nmol/l) is proposed as indicative of a UTI
(Lundin et al. 1989). A minority of patients (n = 3; 6%) was
found to have urinary ATP levels ≥50 nmol/l. Of those test-
ing positive, all 3 also tested positive for the presence of bac-
teria above 105 CFU ml−1. Conversely, 77% patients (n = 41)
with a urinary concentration <50 nmol/l tested negative
for the presence of bacteria (i.e. <105 CFU ml−1). A sig-
nificant association of the ‘gold-standard’ test and urin-
ary ATP concentration was determined using the
Fisher’s exact test (P < 0.01).
Cytospin urine samples from the majority of patients
(n = 41; 77%) contained >3 urothelial cells. Of those
found to have shed urothelial cells, the majority (n = 23;
56%) had urothelial cells that contained intracellular
bacteria (determined using acridine orange (Miliotis
1991); see Figure 1). Interestingly of the 23 patients with
urinary epithelial cells containing bacteria, 22 went on
Table 1 Formulae for test metrics used to evaluate the
performance of diagnostic tests
Test Metric Formula
Sensitivity TP/(TP + FN)
Specificity TN/(TN + FP)
Positive Predictive Value (PPV) TP/(TP + FP)
Positive Likelihood Ratio (LR+) Sensitivity/(1-Specificity)
Negative Likelihood Ratio (LR-) (1-Sensitivity)/Specificity
Accuracy (TP + TN)/(TP + TN + FP + FN)
Youden’s Index Sensitivity + Specificity −1
Diagnostic Odds Ratio (DOR) (TP/FN)/(FP/TN)
Key: TP, TN, FP, and FN denote the number of true positives, true negatives,
false positives, and false negatives, respectively.
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to be classified as bacteria culture negative (i.e.
<105 CFU ml−1) and consequently deemed not to have a
UTI. It was qualitatively noted that if intracellular bac-
teria were identified in one urothelial cell it would also
be identified in accompanying shed urothelial cells. A
significant association of the ‘gold-standard’ test and the
presence of intracellular bacteria in shed urothelial cells
were determined using the Fisher’s exact test (P < 0.01).
When combining the concentration of ATP, ≥50 nM (in
50 μl of fresh unspun urine) with the observation of
urinary epithelial cells containing bacteria (in 100 μl of
fresh urine), one patient (2%) showed parity. In contrast,
a concentration of ATP <50 nM and an absence of intra-
cellular bacteria in shed urinary epithelial cells was ob-
served in 17 patients (32%). Of the 17 patients, all were
culture negative (<105 CFU ml−1). A significant associ-
ation of the ‘gold-standard’ test and combined urinary
ATP concentration and evidence of intracellular bacteria
in shed epithelial cells was determined using the Fisher’s
exact test (P < 0.01). The main results of this study are
summarized in Table 2.
Various urinalysis techniques were evaluated across a
range of quantitative indicators. Measurement of urinary
ATP concentration, when compared to the ‘gold-standard’,
evidenced strong effectiveness as a diagnostic test for UTI
in renal transplant patients. This was reflected in the high
degree of specificity, PPV, LR+, LR-, and accuracy of the
diagnostic test. Additionally, the urinary ATP concentration
diagnostic test evidenced strong effectiveness in both the
Youden’s index and DOR, both important measures of diag-
nostic test accuracy and performance (Glas et al. 2003).
ATP concentration outperformed all the other diagnostic
tests on these metrics with the sole exception of urinary
ATP concentration combined with identification of intracel-
lular bacteria. This combined diagnostic screen outper-
formed all the diagnostic tests for UTI in this study. This
was evidenced in the unison values obtained for selectivity,
specificity, PPV, and accuracy, in addition to the compara-
tively strong measurements of 1 and 105 obtained for the
Youden’s index and DOR, respectively. Statistical analyses of
the main results in this study are summarized in Table 3.
Putting aside RTRs, it is apparent that the standard
clinical methods for diagnosing UTIs are fallible and this
may result in delayed or missed diagnosis with signifi-
cant clinical consequences. There remains a high range
of variability between methods, the ‘gold-standard’ of
bacterial culturing is a fundamentally flawed process and
the sensitivity and specificity of dipstick tests (alone or
combined) leave much to be desired. Here we highlight
this as especially relevant to RTRs.
The inadequacy of current UTI diagnosis in RTRs
Standard laboratory methods for analysing MSU samples
are set at a threshold of 105 CFU ml−1 (Stamm et al.
1982). Hooton & Stamm demonstrated that laboratory
MSU cultures fail to detect over 50% of genuine infections
Figure 1 Shed urothelial cell with evidence of intracellular bacteria. Intracellular localization of bacteria was confirmed by staining with
acridine orange and counterstaining with crystal violet; viewed using the x60 objective on a fluorescence microscope. Immunocytochemistry with
anti-UPIII (FITC; green) confirmed that cells were urothelial.
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in women when using this threshold (Hooton and Stamm
1997). In part this may be explained by current culture
methods assuming dominant pathogenicity from the
Enterobacteriaceae species, notably Escherichia coli, and
owing to this presumption, MSU culture is performed on
selective chromogenic medium for Enterobacteriaceae
under aerobic conditions. As such, anaerobic bacteria
present will not be cultivated and some species of aerobic
bacteria may be overlooked. The same is inherently true
for RTRs.
Numerous studies have described the rapid dipstick
tests as unreliable. Although the nitrite test is reported
as having excellent specificity (0.85-0.98), its sensitivity
(0.45-0.60) is questionable (Deville et al. 2004). When
compared to bacteria culture, previous studies have
demonstrated a failure to detect between 20-60% of
UTIs (Deville et al. 2004; Semeniuk and Church 1999).
Here, using a cohort of RTRs, we report similar specifi-
city values (0.83-0.99), however, dissimilar sensitivity
(0.02-0.48). Interestingly, none of the RTRs presenting
with intracellular bacteria in this study gave a positive
nitrite result (data not shown). Conversely, the leukocyte
esterase dipstick has greater sensitivity (0.21-0.79), but
the specificity (0.00-0.13) seems poor for RTRs. The
values for sensitivity compare favourably to values re-
ported for non-RTR cohorts (0.48-0.86), however as with
the nitrite test, specificity differs (0.17-0.93 (Deville et al.
2004)). Perhaps not surprisingly, in our results 87% of
RTRs had a UTI according to the leukocyte esterase dip-
stick test. It is noteworthy that a positive leukocyte ester-
ase dipstick test may indicate cystitis (of a non-bacterial
origin) and interstitial nephritis. Despite the recommen-
dation that nitrite and leukocyte esterase dipsticks
should be used in combination, this may not always be
Table 2 Contingency tables detailing comparison of surrogate markers to the ‘gold-standard’ for UTI diagnosis
(bacterial culture), in a cohort of renal transplant recipients













Leukocyte positive 6 (11%) 40 (76%) Nitrite positive 2 (4%) 2 (4%) Both positive 0 (4%) 2 (4%)
Leukocyte negative 6 (11%) 1 (2%) Nitrite negative 10 (19%) 39 (73%) Both negative 4 (8%) 1 (2%)













Pyuria positive 9 (17%) 35 (66%) ATP >50 nmol/l 3 (6%) 0 (0%) IB positive 1 (2%) 22 (41%)
Pyuria negative 3 (6%) 6 (11%) ATP <50 nmol/l 9 (17%) 41 (77%) IB negative 11 (21%) 19 (36%)
(7) Combined ATP and IB**
Culture positive Culture negative
ATP >50, IB positive 1 (2%) 0 (0%)
ATP <50, IB negative 0 (0%) 18 (34%)
*denotes Fisher’s exact test <0.05. **denotes Fisher’s exact test =0.0556 (not quite significant). See Methods for an explanation of the surrogate markers used.
Key: IB, intracellular bacteria.
Data not included in the contingency tables: with respect to combined dipstick tests; 6 patients (10%) were leukocyte positive/nitrite negative and culture
positive; 37 patients (70%) were leukocyte positive/nitrite negative and culture negative; 2 patients (4%) where leukocyte negative/nitrite positive and culture
positive; 1 patient (2%) was where leukocyte negative/nitrite positive and culture negative. With respect to combined ATP and IB; 9 patients (17%) were IB
positive/ATP <50 and culture positive; 22 patients (41%) were IB positive/ATP <50 and culture negative; 3 patients (6%) were IB negative/ATP >50 and culture
positive; 0 patients were IB negative/ATP >50 and culture negative.
Table 3 Comparison of variables to determine the power of surrogate markers to the ‘gold-standard’ for UTI diagnosis







LR+ LR- Accuracy Youden’s index DOR
(95% CL)
(1) Leukocyte esterase 0.500 (0.21-0.79) 0.024 (0.00-0.13) 0.130 (0.05-0.26) 0.513 20.5 0.132 −0.476 0.025 (0.00-0.25)
(2) Nitrite 0.167 (0.02-0.48) 0.951 (0.83-0.99) 0.500 (0.07-0.93) 3.417 0.876 0.774 0.118 3.900 (0.49-31.22)
(3) Combined dipsticks 0.000 (0.00-0.60) 0.333 (0.01-0.91) 0.000 (0.00-0.84) 0.000 3.000 0.143 −0.667 0.067 (0.00-2.33)
(4) Pyuria 0.750 (0.43-0.95) 0.146 (0.06-0.29) 0.205 (0.10-0.35) 0.879 1.708 0.283 −0.104 0.514 (0.11-2.47)
(5) ATP 0.250 (0.05-0.57) 1.000 (0.91-1.00) 1.000 (0.29-1.00) Infinity 0.750 0.830 0.250 30.580 (1.45-643.50)
(6) IB 0.083 (0.00-0.38) 0.463 (0.31-0.63) 0.043 (0.00-0.22) 0.155 1.978 0.377 −0.453 0.079 (0.01-0.67)
(7) Combined ATP and IB 1.000 (0.03-1.00) 1.000 (0.81-1.00) 1.000 (0.03-1.00) Infinity 0.000 1.000 1.000 105.000 (1.48-7441.80)
Key: PPV, positive predictive value; LR+, positive likelihood ratio; LR-, negative likelihood ratio; DOR, diagnostic odds ratio; IB, intracellular bacteria.
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the case. Furthermore, with respect to the RTRs, this
does little to improve the diagnostic power of these tests
(see Table 3).
Our data confirms the notion that many of the described
inadequacies in current urinalysis become more apparent
when studying RTRs. The consequences of misdiagnosis
in this cohort are far reaching, with APN being diagnosed
in approximately a third of all patients with a UTI at one
time or another post-transplant (Valera et al. 2006).
Promising new tests for UTI diagnosis in RTRs
Of great interest are our results for urinary ATP concen-
tration as a marker of UTIs in RTRs, which showed a
significant association to ‘gold-standard’ bacterial culture
results. Similar to the principle behind the nitrite
dipstick, these data suggests that urinary ATP <50 nmol/
l may be a useful tool in ruling out a UTI (see Table 3).
The concentration of ATP from those RTRs that were
subsequently found to be culture positive was ~10-fold
lower than those seen in the previous study by Lundin
et al. using a cohort of non-transplant patients (Lundin
et al. 1989). We speculate the cause of a lower urinary
ATP concentration is due to immunosuppression and
fewer WBCs in the urine, as bacterial infection also
induces the release of ATP from immune cells (Rizzo
et al. 2009). Although not investigated here, there may
be merit in re-evaluating the concentration of ATP (cur-
rently set at ≥50 nM, in 50 μl of fresh unspun urine, by
Lunden et al. (Lundin et al. 1989)) that is indicative of a
UTI with special reference to RTRs. Although haema-
turia was not evident in these patients, it is noteworthy
that blood ATP concentration, in healthy subjects at
least, can be relatively high 200 nM - 600 μM (Chida
et al. 2013; Praetorius and Leipziger 2009). Since the
major source of ATP in blood is red blood cell, haema-
turia may exclude urinary ATP concentration as a
marker of UTIs in RTRs.
It has been proposed that many recalcitrant, and pos-
sible recurrent, UTIs are the result of an underlying in-
fection caused by quiescent intracellular bacteria present
in the transitional cell layer of the urothelium (Anderson
et al. 2003), this may be most apposite for immunosup-
pressed RTRs. When comparing the proportion of RTRs
with intracellular bacteria, with a similar study using pa-
tients with no other complications aside from UTIs we
see a marked difference in results. We find 44% of our
RTR cohort to have intracellular bacteria, whereas Rosen
et al. found intracellular bacteria in just 18% of their
UTI cohort (Rosen et al. 2007). This suggests a greater
prevalence of intracellular bacteria in RTRs, and may ac-
count for the higher incidence of recurrent UTIs in
RTR. This could be explained in part by these patients
being immunosuppressed and having a reduced defense
against invading bacteria. The primary defence against
uropathogenic bacteria are phagocytic neutrophils re-
cruited from the bloodstream directly to the site of
invading bacteria (Kobayashi et al. 2003). Interestingly, we
see that the urinary WBC count is significantly decreased
in RTRs when compared to the ‘normal’ UTI patients
(data not shown).
Perhaps the most important finding of the current
study is the superior diagnostic ability of combining
urinary ATP concentration with evidence of intracellular
bacteria in shed urothelial cells compared to the current
gold-standard (albeit an inadequate gold-standard). In
our cohort of RTRs this combination yielded encour-
aging sensitivity and specificity values, as well as un-
rivalled PPV, LR+, accuracy, Youden’s index and DOR
(see Table 2). These results suggest a low urinary ATP
concentration and an absence of intracellular bacteria in
shed urinary epithelial cells may be a powerful tool for
ruling out UTIs (symptomatic, asymptomatic, or sub-
clinical) and/or the likelihood of recurrent UTIs in RTRs
(i.e. a negative diagnostic of UTI). ‘Ruling out’ being
analogous to current cytomegalovirus (CMV) tests
(using polymerase chain reaction [PCR] technology) in
transplantation. However, in the current investigation we
hypothesised: bacterial colonization of shed urothelial
cells and high levels of urinary ATP (>50 nmol/l; pre-
sumably as a result of a proinflammatory response in-
volving the purinergic system) is a powerful marker of
UTI in RTRs when compared to the current ‘gold stand-
ard’ culture test. We believe that a subsequent larger
longitudinal study into the natural history of UTIs in
RTRs will further substantiate/prove our hypothesis.
Furthermore, it will be interesting to see if this com-
bined diagnostic methodology (ATP and intracellular
bacteria), if introduced, would predict patients who sub-
sequently go on to develop clinically important UTIs.
Conclusions
In conclusion, we provide evidence of urinary tract disease
in RTRs when routine clinical tests are negative, and
thereby validate the suspicion of missed diagnosis. We
propose that concealed infection through intracellular
bacterial colonization of urothelial cells may account for
recurrent UTIs seen in RTRs, which presents a real and
serious concern. Finally we propose additional/alternative
urinalysis for diagnosing UTIs in RTRs. We now need to
build on this cross-sectional, one-time sampling, prelimin-
ary investigation by following RTRs for a sustained period,
also investigating reproducibility (i.e. how often you can
repeat the test in the same patients with the same results),
and perhaps investigate the outcomes of those RTRs fol-
lowing treatment regimes based on standard UTI detec-
tion practice and the novel techniques we propose (i.e.
urinary ATP concentration and evidence of intracellular
bacteria in shed urothelial cells).
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